| Business Summary | | Eisai
Co.,
Ltd.
manufactures
and
sells
value-added
prescription
drugs
as
well
as
consumer
health
care
products
and
pharmaceutical
production
systems
and
equipment. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Eisai
Co.,
Ltd.
manufactures
and
sells
innovative
and
value-added
prescription
drugs
as
well
as
consumer
health
care
products
and
pharmaceutical
production
systems
and
equipment.
For
the
fiscal
year
ended
3/31/00,
revenues
rose
6%
to
Y302.47
billion.
Net
income
decrease
29%
to
Y11.28
billion.
Revenues
reflect
the
launch
of
Aricept
and
strong
overseas
sales.
Earnings
were
offset
by
increased
S/G/A
expenses
and
a
Y9.97
billion
loss
on
the
vitamin
E
cases. | More
from
Market Guide: Significant
Developments |
| Officers | | Haruo
Naito,
Pres./CEO Yuji
Naito,
Chmn. Hiromasa
Nakai,
Exec. VP Soichi
Matsuno,
Sr. VP. | More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|